Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,815
Closed -$1.07M 253
2019
Q3
$1.07M Sell
10,815
-12
-0.1% -$1.14K 0.08% 165
2019
Q2
$1M Sell
10,827
-2,381
-18% -$226K 0.07% 168
2019
Q1
$1.25M Sell
13,208
-1,446
-10% -$126K 0.09% 149
2018
Q4
$939K Sell
14,654
-3,194
-18% -$236K 0.07% 185
2018
Q3
$1.59M Buy
17,848
+150
+0.8% +$13.3K 0.1% 161
2018
Q2
$1.41M Sell
17,698
-2,374
-12% -$197K 0.09% 162
2018
Q1
$1.79M Sell
20,072
-2,687
-12% -$258K 0.11% 140
2017
Q4
$2.38M Sell
22,759
-55
-0.2% -$6.21K 0.14% 118
2017
Q3
$3.33M Sell
22,814
-3,735
-14% -$509K 0.2% 104
2017
Q2
$3.5M Sell
26,549
-535
-2% -$65.6K 0.18% 113
2017
Q1
$3.37M Buy
27,084
+570
+2% +$68.2K 0.17% 113
2016
Q4
$3.07M Sell
26,514
-3,804
-13% -$424K 0.16% 115
2016
Q3
$3.17M Buy
30,318
+136
+0.5% +$14.7K 0.16% 130
2016
Q2
$2.98M Buy
30,182
+3,414
+13% +$353K 0.15% 129
2016
Q1
$2.68M Sell
26,768
-1,252
-4% -$129K 0.13% 131
2015
Q4
$3.36M Sell
28,020
-2,436
-8% -$282K 0.16% 130
2015
Q3
$3.29M Sell
30,456
-5,613
-16% -$697K 0.17% 125
2015
Q2
$4.17M Sell
36,069
-3,737
-9% -$427K 0.19% 121
2015
Q1
$4.59M Sell
39,806
-3,609
-8% -$431K 0.19% 121
2014
Q4
$4.86M Sell
43,415
-3,745
-8% -$395K 0.21% 117
2014
Q3
$4.47M Sell
47,160
-7,134
-13% -$644K 0.19% 122
2014
Q2
$4.66M Sell
54,294
-2,624
-5% -$200K 0.2% 125
2014
Q1
$3.97M Sell
56,918
-8,736
-13% -$692K 0.17% 130
2013
Q4
$5.55M Sell
65,654
-84,080
-56% -$6.65M 0.24% 107
2013
Q3
$11.5M Sell
149,734
-80,632
-35% -$5.65M 0.54% 64
2013
Q2
$14.2M Buy
+230,366
New +$13.9M 0.65% 53

Other funds holding CELG

TDAM USA's CELG Position: Q4 2019 in Review

TDAM USA sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 10,815 shares — an estimated $1.07M sold.

TDAM USA first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $14.2M in Q2 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • TDAM USA reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • TDAM USA sold 10,815 Celgene Corp shares in Q4 2019, an estimated $1.07M.
  • TDAM USA first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • TDAM USA's Celgene Corp position peaked at $14.2M in Q2 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on TDAM USA's 13F filing for Q4 2019, filed 11 Feb 2020.